Cancer cell invasion and EMT marker expression: a three-dimensional study of the human cancer-host interface
- PMID: 25081610
- DOI: 10.1002/path.4416
Cancer cell invasion and EMT marker expression: a three-dimensional study of the human cancer-host interface
Abstract
Cancer cell invasion takes place at the cancer-host interface and is a prerequisite for distant metastasis. The relationships between current biological and clinical concepts such as cell migration modes, tumour budding and epithelial-mesenchymal transition (EMT) remains unclear in several aspects, especially for the 'real' situation in human cancer. We developed a novel method that provides exact three-dimensional (3D) information on both microscopic morphology and gene expression, over a virtually unlimited spatial range, by reconstruction from serial immunostained tissue slices. Quantitative 3D assessment of tumour budding at the cancer-host interface in human pancreatic, colorectal, lung and breast adenocarcinoma suggests collective cell migration as the mechanism of cancer cell invasion, while single cancer cell migration seems to be virtually absent. Budding tumour cells display a shift towards spindle-like as well as a rounded morphology. This is associated with decreased E-cadherin staining intensity and a shift from membranous to cytoplasmic staining, as well as increased nuclear ZEB1 expression.
Keywords: cancer cell invasion; epithelial-mesenchymal transition; human adenocarcinoma; three-dimensional reconstruction; tumour budding.
Copyright © 2014 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Similar articles
-
Detailed analysis of epithelial-mesenchymal transition and tumor budding identifies predictors of long-term survival in pancreatic ductal adenocarcinoma.J Gastroenterol Hepatol. 2015 Mar;30 Suppl 1:78-84. doi: 10.1111/jgh.12752. J Gastroenterol Hepatol. 2015. PMID: 25827809
-
Form follows function: Morphological and immunohistological insights into epithelial-mesenchymal transition characteristics of tumor buds.Tumour Biol. 2017 May;39(5):1010428317705501. doi: 10.1177/1010428317705501. Tumour Biol. 2017. PMID: 28475002
-
Tumor budding at the invasive front of colorectal cancer may not be associated with the epithelial-mesenchymal transition.Hum Pathol. 2017 Feb;60:151-159. doi: 10.1016/j.humpath.2016.10.007. Epub 2016 Nov 9. Hum Pathol. 2017. PMID: 27836787
-
The role of epithelial-mesenchymal transition in cancer pathology.Pathology. 2007 Jun;39(3):305-18. doi: 10.1080/00313020701329914. Pathology. 2007. PMID: 17558857 Review.
-
Tumour budding in colorectal cancer: what do we know and what can we do?Virchows Arch. 2016 Apr;468(4):397-408. doi: 10.1007/s00428-015-1886-5. Epub 2015 Nov 27. Virchows Arch. 2016. PMID: 26613731 Review.
Cited by
-
A Recipe for Successful Metastasis: Transition and Migratory Modes of Ovarian Cancer Cells.Cancers (Basel). 2024 Feb 15;16(4):783. doi: 10.3390/cancers16040783. Cancers (Basel). 2024. PMID: 38398174 Free PMC article. Review.
-
Secreted TGF-beta-induced protein promotes aggressive progression in bladder cancer cells.Cancer Manag Res. 2019 Jul 25;11:6995-7006. doi: 10.2147/CMAR.S208984. eCollection 2019. Cancer Manag Res. 2019. PMID: 31440088 Free PMC article.
-
Tumour budding is a novel marker in breast cancer: the clinical application and future prospects.Ann Med. 2022 Dec;54(1):1303-1312. doi: 10.1080/07853890.2022.2070272. Ann Med. 2022. PMID: 35535687 Free PMC article. Review.
-
Epithelial-Mesenchymal Plasticity in Tumor Immune Evasion.Cancer Res. 2022 Jul 5;82(13):2329-2343. doi: 10.1158/0008-5472.CAN-21-4370. Cancer Res. 2022. PMID: 35363853 Free PMC article. Review.
-
Development of a Novel 3D Tumor-tissue Invasion Model for High-throughput, High-content Phenotypic Drug Screening.Sci Rep. 2018 Aug 29;8(1):13039. doi: 10.1038/s41598-018-31138-6. Sci Rep. 2018. PMID: 30158688 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
